<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04892108</url>
  </required_header>
  <id_info>
    <org_study_id>129/2021/Sper/AOUFe</org_study_id>
    <nct_id>NCT04892108</nct_id>
  </id_info>
  <brief_title>Rectal Prolapse With ODS. STARR vs LVR.</brief_title>
  <official_title>Surgical Treatment of Internal Rectal Prolapse Associated With Obstructed Defecation: Transanal Prolassectomy Versus Laparoscopic Ventral Rectopexy. Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Ferrara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Ferrara</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study will be to evaluate the clinical and functional outcome of&#xD;
      patients with obstructed defecation sndrome (ODS) associated to internal rectal prolapse,&#xD;
      treated with transanal prolassectomy (STARR) surgery compared to those treated with&#xD;
      laparoscopic ventral rectopexy (LVR).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized controlled trial (single center, prospective, randomized controlled,&#xD;
      parallel, and single-blind trial) is designed to compare the outcome of patients with ODS and&#xD;
      rectal prolapse undergoing transanal prolapsectomy with mechanical stapler (STARR) versus&#xD;
      laparoscopic ventral rectopexy (LVR), with the aim of evaluating the most appropriate&#xD;
      surgical choice.&#xD;
&#xD;
      The study will be conducted at the Surgical Unit 2 of the University Hospital of Ferrara,&#xD;
      Italy. Patients suffering from rectal prolapse and ODS that will refer to the colorectal and&#xD;
      pelvic floor clinic of the University Hospital Ferrara, and eligible for surgery, will be&#xD;
      evaluated consecutively after expressing consent to participate in the study by signing an&#xD;
      informed consent.&#xD;
&#xD;
      The duration of the study for each patient will be expected to be 48 months with follow-up at&#xD;
      1, 3, 6, 12, 24, 36, and 48 months postoperatively.&#xD;
&#xD;
      Eligible patients will receive information about participating in the trial by their surgeon.&#xD;
      Consecutive eligible patients will be randomly assigned to one of two groups with a 1:1 equal&#xD;
      allocation ratio.&#xD;
&#xD;
      Patients eligible for the study will be randomized on a 1:1 basis to undergo transanal&#xD;
      prolassectomy (Group 1: STARR) or laparoscopic ventral rectopexy with mesh placement (Group&#xD;
      2: LVR).&#xD;
&#xD;
      An independent individual will perform randomization using a software randomization program.&#xD;
      Randomization will be performed by a randomized list. The assignment sequence will be&#xD;
      generated from a random numerical series generated through a computerized list. Randomization&#xD;
      will be in blocks of 4. Group assignments will be unknown to those responsible for data&#xD;
      collection and those who will be responsible for statistical analysis and clinical evaluation&#xD;
      of patients.&#xD;
&#xD;
      The diagnosis of ODS will be attributed after clinical evaluation at the colorectal clinic&#xD;
      and on the basis of the presence of one or more symptoms associated with this disorder, such&#xD;
      as to reach a score of 14 and above according to the validated score of ODS of Altomare.&#xD;
&#xD;
      Assessment After recruitment and consent, all patients under study will be asked and&#xD;
      collected demographic and clinical information with comorbidities (in particular diabetes,&#xD;
      fibromyalgia, depressive disorders, neurological diseases, COPD), parity, previous pelvic&#xD;
      surgery, type of surgery, time of hospitalization and any complications (according to&#xD;
      Clavien-Dindo classification).&#xD;
&#xD;
      Data concerning the grade of rectoanal prolapse, according with Oxford Classification [20],&#xD;
      and rectocele grading will be collected through outpatient proctological evaluation&#xD;
      associated with proctoscopy, rectal manometry, and Rx defecography. Colonoscopy will be also&#xD;
      performed in every patient to exclude colorectal cancer.&#xD;
&#xD;
      The severity of the ODS will be scored with the Altomare's ODS scoring system. Constipation&#xD;
      and fecal incontinence will be measured by obtaining their scores through the administration&#xD;
      of validated questionnaires such as the Wexner Constipation score, and the Cleveland Clinic&#xD;
      Fecal Incontinence Score (CCFI).&#xD;
&#xD;
      Quality of life will be also evaluated by the patient assessment of constipation&#xD;
      quality-of-life (PAC-Qol) questionnaire. The study of eventually associated pelvic distress&#xD;
      will be assessed by administering validated questionnaires such as the Pelvic Floor Distress&#xD;
      Inventory (PFDI-score, short form) and the Pelvic Floor Impact Questionnaire (PFQI-score,&#xD;
      short form).&#xD;
&#xD;
      The scores obtained, as well as the presence of symptoms (fecal incontinence, constipation,&#xD;
      or ODS) will be calculated before and after surgery (at 6, 12, 24, 36, and 48 months). All&#xD;
      patients will be followed up on an outpatient basis at 7 days, 1 month, 3 months, 6 months,&#xD;
      12 ,24, 36, and 48 months after surgery. Rectal manometry and defecography will be performed&#xD;
      after 12 months after surgery.&#xD;
&#xD;
      Surgical intervention All the procedures will be performed by a single surgeon (SA). The LVR&#xD;
      technique used for this protocol is as previously described. Subjects randomized to this arm&#xD;
      will receive a standard LVR. Briefly, the peritoneum is opened over the right side of the&#xD;
      sacral promontory. The mesorectum is dissected and extended in an inverted J-form along the&#xD;
      right side. The rectovaginal septum is opened to the pelvic floor. Biologic mesh (Permacol)&#xD;
      is sutured to the ventral aspect of the rectum with non-readsorbable stitches. The proximal&#xD;
      end of the mesh is fixed on the anterior longitudinal ligament at sacral promontory with&#xD;
      nonabsorbable tacks. The incised peritoneum is then closed to over the mesh.&#xD;
&#xD;
      Subjects randomized to STARR arm will undergo a STARR procedure. Briefly, a circular anal&#xD;
      dilator is introduced into the rectum. The purse-string anoscope is used to complete the&#xD;
      anterior hemi-circumference purse-string suture, about 2-3 cm above the haemorrhoidal apex. A&#xD;
      33-mm circular stapler (Ethicon, ppH01) is opened, inserted until crossing the purse-string&#xD;
      which is then tied with a knot. Then the stapler is closed and fired. The same&#xD;
      hemi-circumference purse-string suture is performed in the posterior rectal wall. A second&#xD;
      application of the stapler on the posterior wall is inserted, closed and fired.&#xD;
&#xD;
      The duration of the study will be 2 years. The study will be conducted in accordance with the&#xD;
      principles of Helsinki Declaration, with approval of the medical ethics review board of S.&#xD;
      Anna University Hospital. A written informed consent will be obtained from all enrolled&#xD;
      patients.&#xD;
&#xD;
      The report will comply with the strengthening the reporting of randomized studies (CONSORT).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">March 1, 2021</completion_date>
  <primary_completion_date type="Actual">January 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This randomized controlled trial is designed to compare the outcome of patients with obstructed defecation syndrome (ODS) and rectal prolapse undergoing transanal prolassectomy surgery with mechanical stapler (STARR: stapled transanal rectal resection) versus laparoscopic ventral rectopexy (LVR) surgery, with the aim of evaluating the most appropriate surgical choice. Patients eligible for the study will be randomized on a 1:1 basis to undergo transanal prolassectomy (Group 1: STARR) or laparoscopic ventral rectopexy with mesh placement (Group 2: LVR).&#xD;
Randomization will be performed by a randomized list. The assignment sequence will be generated from a random numerical series generated through a computerized list. Randomization will be in blocks of 4. Group assignments will be unknown to those responsible for data collection and those who will be responsible for statistical analysis and clinical evaluation of patients.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of different outcomes in relief from ODS after surgery in both groups</measure>
    <time_frame>4 years</time_frame>
    <description>In order to evaluate the short- and long-term efficacy of STARR procedure compared to LVR, the percentage of changes in total ODS, PAC-QoL, PFDI, PFQI, Wexner Constipation, the Cleveland Clinic Fecal Incontinence (CCFI) scores between baseline and 6, 12, 24, 36, and 48 months after surgery, were adopted as primary outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>short-term postoperative complications (within 30 days after surgery)</measure>
    <time_frame>4 years</time_frame>
    <description>short-term postoperative complications (within 30 days after surgery) in the two groups (according to Clavien-Dindo classification)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>long-term postoperative complications</measure>
    <time_frame>4 years</time_frame>
    <description>Mesh-related complications, rectal stenosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recurrence or persistence of rectal prolapse</measure>
    <time_frame>4 years</time_frame>
    <description>to evaluate recurrence or persistence of rectal prolapse (diagnosed clinically and by postoperative defecography) in both groups, and the need for subsequent corrective surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recurrence or persistence of ODS (Obstructed defecation syndrome)</measure>
    <time_frame>4 years</time_frame>
    <description>recurrence or persistence of ODS if ODS score &gt; 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction in terms of pain</measure>
    <time_frame>4 years</time_frame>
    <description>patient satisfaction measured by a VAS (Visual Analogue Scale: evaluation of pain in mm: from 0 to 4 mm: no pain; from 5 to 44 mm: little pain; from 45 to 74 mm: moderate pain; from 75 to 100 mm: severe pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Rectal Prolapse</condition>
  <condition>Defecation Disorder</condition>
  <condition>Rectocele; Female</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Group STARR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergoing transanal prolassectomy with mechanical stapler (STARR: Stapled Trans Anal Rectal Resection) randomly</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group LVR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergoing Laparoscopic suspensory correction of rectal prolapse by ventral rectopexy with biological prosthesis (LVR) randomly</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>STARR (Stapled Trans Anal Rectal Resection)</intervention_name>
    <description>Patients randomly assigned to surgical intervention of STARR (Stapled Trans Anal Rectal Resection)</description>
    <arm_group_label>Group STARR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LVR (Laparoscopic Ventral Rectopexy)</intervention_name>
    <description>Patients randomly assigned to surgical intervention of LVR (Laparoscopic Ventral Rectopexy)</description>
    <arm_group_label>Group LVR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  female gender,&#xD;
&#xD;
          -  the presence of rectorectal or rectoanal intussusception as main cause of ODS,&#xD;
             confirmed by defecography,&#xD;
&#xD;
          -  type of operation performed (STARR or LVR),&#xD;
&#xD;
          -  ODS score &gt; 14 [17]&#xD;
&#xD;
          -  PACQoL &gt;32 [18]&#xD;
&#xD;
          -  ODS symptoms for at least 12 months prior to enrollment&#xD;
&#xD;
          -  Failure of at least 6 months of medical therapy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  male gender,&#xD;
&#xD;
          -  severe fecal incontinence (CCS score&gt;6, Maximum Resting Pressure at rectal manometry &lt;&#xD;
             50 mmHg),&#xD;
&#xD;
          -  combined procedures&#xD;
&#xD;
          -  previous surgery on rectum or anus for cancer or rectal prolapse, inflammatory bowel&#xD;
             disease, other type of surgery to relieve ODS&#xD;
&#xD;
          -  pregnancy,&#xD;
&#xD;
          -  anismus or dissinergic defecation&#xD;
&#xD;
          -  full-thickness prolapse&#xD;
&#xD;
          -  stress urinary incontinence associated&#xD;
&#xD;
          -  histerocele or cystocele associated (since we usually correct both defects in the same&#xD;
             surgical procedure)&#xD;
&#xD;
          -  prior pelvic radiotherapy&#xD;
&#xD;
          -  slow transit constipation defined as ≤ 2 bowel movements per week,&#xD;
&#xD;
          -  any psychiatric diseases.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simona Ascanelli</last_name>
    <role>Principal Investigator</role>
    <affiliation>Surgical Department University Hospital Ferrara Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Surgery 2 Surgical Department, Sant'Anna University Hospital Ferrara, Italy</name>
      <address>
        <city>Ferrara</city>
        <zip>44124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Hicks CW, Weinstein M, Wakamatsu M, Savitt L, Pulliam S, Bordeianou L. In patients with rectoceles and obstructed defecation syndrome, surgery should be the option of last resort. Surgery. 2014 Apr;155(4):659-67. doi: 10.1016/j.surg.2013.11.013. Epub 2013 Dec 5.</citation>
    <PMID>24508117</PMID>
  </reference>
  <reference>
    <citation>Khaikin M, Wexner SD. Treatment strategies in obstructed defecation and fecal incontinence. World J Gastroenterol. 2006 May 28;12(20):3168-73. Review.</citation>
    <PMID>16718835</PMID>
  </reference>
  <reference>
    <citation>Rao SS. Dyssynergic defecation. Gastroenterol Clin North Am. 2001 Mar;30(1):97-114. Review.</citation>
    <PMID>11394039</PMID>
  </reference>
  <reference>
    <citation>Podzemny V, Pescatori LC, Pescatori M. Management of obstructed defecation. World J Gastroenterol. 2015 Jan 28;21(4):1053-60. doi: 10.3748/wjg.v21.i4.1053. Review.</citation>
    <PMID>25632177</PMID>
  </reference>
  <reference>
    <citation>Gunner CK, Senapati A, Northover JM, Brown SR. Life after PROSPER. What do people do for external rectal prolapse? Colorectal Dis. 2016 Aug;18(8):811-4. doi: 10.1111/codi.13255.</citation>
    <PMID>27481719</PMID>
  </reference>
  <reference>
    <citation>Senapati A, Gray RG, Middleton LJ, Harding J, Hills RK, Armitage NC, Buckley L, Northover JM; PROSPER Collaborative Group. PROSPER: a randomised comparison of surgical treatments for rectal prolapse. Colorectal Dis. 2013 Jul;15(7):858-68. doi: 10.1111/codi.12177.</citation>
    <PMID>23461778</PMID>
  </reference>
  <reference>
    <citation>Emile SH, Elfeki H, Shalaby M, Sakr A, Sileri P, Wexner SD. Perineal resectional procedures for the treatment of complete rectal prolapse: A systematic review of the literature. Int J Surg. 2017 Oct;46:146-154. doi: 10.1016/j.ijsu.2017.09.005. Epub 2017 Sep 7. Review.</citation>
    <PMID>28890414</PMID>
  </reference>
  <reference>
    <citation>van den Esschert JW, van Geloven AA, Vermulst N, Groenedijk AG, de Wit LT, Gerhards MF. Laparoscopic ventral rectopexy for obstructed defecation syndrome. Surg Endosc. 2008 Dec;22(12):2728-32. doi: 10.1007/s00464-008-9771-9. Epub 2008 Mar 5. Erratum in: Surg Endosc. 2008 Oct;22(10):2330. Groenedijk, A [corrected to Groenedijk, A G].</citation>
    <PMID>18320283</PMID>
  </reference>
  <reference>
    <citation>Altomare DF, Spazzafumo L, Rinaldi M, Dodi G, Ghiselli R, Piloni V. Set-up and statistical validation of a new scoring system for obstructed defaecation syndrome. Colorectal Dis. 2008 Jan;10(1):84-8. Epub 2007 Apr 18.</citation>
    <PMID>17441968</PMID>
  </reference>
  <reference>
    <citation>Marquis P, De La Loge C, Dubois D, McDermott A, Chassany O. Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scand J Gastroenterol. 2005 May;40(5):540-51.</citation>
    <PMID>16036506</PMID>
  </reference>
  <reference>
    <citation>Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187-96. doi: 10.1097/SLA.0b013e3181b13ca2.</citation>
    <PMID>19638912</PMID>
  </reference>
  <reference>
    <citation>Cariou de Vergie L, Venara A, Duchalais E, Frampas E, Lehur PA. Internal rectal prolapse: Definition, assessment and management in 2016. J Visc Surg. 2017 Feb;154(1):21-28. doi: 10.1016/j.jviscsurg.2016.10.004. Epub 2016 Nov 16. Review.</citation>
    <PMID>27865742</PMID>
  </reference>
  <reference>
    <citation>Kluivers KB, Hendriks JC, Shek C, Dietz HP. Pelvic organ prolapse symptoms in relation to POPQ, ordinal stages and ultrasound prolapse assessment. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Sep;19(9):1299-302. doi: 10.1007/s00192-008-0634-7. Epub 2008 May 9.</citation>
    <PMID>18465076</PMID>
  </reference>
  <reference>
    <citation>Agachan F, Chen T, Pfeifer J, Reissman P, Wexner SD. A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum. 1996 Jun;39(6):681-5.</citation>
    <PMID>8646957</PMID>
  </reference>
  <reference>
    <citation>Vaizey CJ, Carapeti E, Cahill JA, Kamm MA. Prospective comparison of faecal incontinence grading systems. Gut. 1999 Jan;44(1):77-80.</citation>
    <PMID>9862829</PMID>
  </reference>
  <reference>
    <citation>Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 2005 Jul;193(1):103-13.</citation>
    <PMID>16021067</PMID>
  </reference>
  <reference>
    <citation>Barber MD, Chen Z, Lukacz E, Markland A, Wai C, Brubaker L, Nygaard I, Weidner A, Janz NK, Spino C. Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ). Neurourol Urodyn. 2011 Apr;30(4):541-6. doi: 10.1002/nau.20934. Epub 2011 Feb 22.</citation>
    <PMID>21344495</PMID>
  </reference>
  <reference>
    <citation>Sileri P, Franceschilli L, de Luca E, Lazzaro S, Angelucci GP, Fiaschetti V, Pasecenic C, Gaspari AL. Laparoscopic ventral rectopexy for internal rectal prolapse using biological mesh: postoperative and short-term functional results. J Gastrointest Surg. 2012 Mar;16(3):622-8. doi: 10.1007/s11605-011-1793-2. Epub 2012 Jan 7.</citation>
    <PMID>22228202</PMID>
  </reference>
  <reference>
    <citation>Jayne DG, Schwandner O, Stuto A. Stapled transanal rectal resection for obstructed defecation syndrome: one-year results of the European STARR Registry. Dis Colon Rectum. 2009 Jul;52(7):1205-12; discussion 1212-4. doi: 10.1007/DCR.0b013e3181a9120f.</citation>
    <PMID>19571694</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 11, 2021</study_first_submitted>
  <study_first_submitted_qc>May 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2021</study_first_posted>
  <last_update_submitted>May 25, 2021</last_update_submitted>
  <last_update_submitted_qc>May 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Ferrara</investigator_affiliation>
    <investigator_full_name>Simona Ascanelli</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Obstructed defecation syndrome</keyword>
  <keyword>Transanal rectal prolassectomy</keyword>
  <keyword>Laparoscopic ventral mesh rectopexy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Prolapse</mesh_term>
    <mesh_term>Rectocele</mesh_term>
    <mesh_term>Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>Study Protocol</doc_type>
      <doc_url>https://drive.google.com/drive/folders/10w8pl8TztkdTzafLc-M4wRyrHNZI1G-r?usp=sharing</doc_url>
    </study_doc>
    <study_doc>
      <doc_type>Statistical Analysis Plan</doc_type>
      <doc_url>https://drive.google.com/drive/folders/10w8pl8TztkdTzafLc-M4wRyrHNZI1G-r?usp=sharing</doc_url>
    </study_doc>
    <study_doc>
      <doc_type>Informed Consent Form</doc_type>
      <doc_url>https://drive.google.com/drive/folders/10w8pl8TztkdTzafLc-M4wRyrHNZI1G-r?usp=sharing</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

